Copyright
©The Author(s) 2023.
World J Gastroenterol. Nov 7, 2023; 29(41): 5668-5682
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Variable | Physically active(n = 125) | Physically inactive(n = 94) | P value1 |
IBD | 0.8922 | ||
Crohn’s disease | 53 (42.4%) | 39 (41.5%) | |
Ulcerative colitis | 72 (57.6%) | 55 (58.5%) | |
Age | 39 (29.5-52) | 44 (29-55.25) | 0.506 |
BMI | 24.25 (21.47-26.28) | 22.72 (20.95-25.71) | 0.185 |
Gender | 0.9522 | ||
Male | 67 (53.6%) | 50 (53.2%) | |
Female | 58 (46.4%) | 44 (46.8%) | |
Education | 0.903 | ||
Primary school | 34 (27.2%) | 25 (26.6%) | |
Secondary school | 75 (60%) | 55 (58.5%) | |
Degree | 16 (12.8%) | 14 (14.9%) | |
Job | 0.432 | ||
Unemployed | 59 (47.2%) | 48 (51.1%) | |
Employee | 30 (24%) | 24 (25.5%) | |
Entrepreneur | 15 (12%) | 9 (9.6%) | |
Worker | 6 (4.8%) | 5 (5.3%) | |
Student | 15 (12%) | 8 (8.5%) | |
Smoking status | 0.607 | ||
Active smoker | 21 (16.8%) | 15 (16%) | |
Past smoker | 29 (23.2%) | 19 (20.2%) | |
Non-smoker | 75 (60%) | 60 (63.8%) | |
Alcohol consumer | 0.8922 | ||
Yes | 10 (8%) | 4 (4.3%) | |
No | 115 (92%) | 90 (95.7%) | |
Comorbidity | 0.899 | ||
Diabetes | 8 (6.4%) | 4 (4.3%) | |
Hypertension | 20 (16%) | 10 (10.6%) | |
Recurrent UTI | 3 (3.2%) | 2 (2.1%) | |
Chronic renal failure | - | 1 (1.1%) | |
Nephrolithiasis | 3 (2.4%) | 2 (2.1%) | |
Asthma | 2 (1.6%) | 2 (2.1%) | |
COPD | 1 (0.8%) | 1 (1.1%) | |
Previous pneumonia | 2 (1.6%) | - | |
Dyslipidaemia | 28 (22.4%) | 19 (20.2%) | |
Arthritis | 32 (25.6%) | 34 (36.2%) | |
Hashimoto’s Thyroiditis | 12 (9.6%) | 10 (10.6%) | |
Partner | 0.5702 | ||
Yes No | 86 (68.8%) 39 (31.2%) | 68 (72.3%) 26 (27.7%) | |
Biologics(yes) | 91 (72.8%) | 63 (67%) | 0.3542 |
Steroids(yes) | 10 (8%) | 2 (2.1%) | 0.0592 |
- Citation: Gravina AG, Pellegrino R, Durante T, Palladino G, D’Onofrio R, Mammone S, Arboretto G, Auletta S, Imperio G, Ventura A, Romeo M, Federico A. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study. World J Gastroenterol 2023; 29(41): 5668-5682
- URL: https://www.wjgnet.com/1007-9327/full/v29/i41/5668.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i41.5668